Literature DB >> 8213021

Effects of flumazenil during administration of midazolam on pial vessel diameter and regional cerebral blood flow in cats.

H Kumano1, T Shimomura, H Furuya, H Yomosa, T Okuda, T Sakaki, M Kuro.   

Abstract

We implanted closed cranial windows in ten cats in order to observe the response of pial vessel diameter by microscopy using fluorescein isothiocyanate-labeled dextran and regional cerebral blood flow (rCBF) by laser Doppler flowmetry during administration of midazolam and reversal with flumazenil. Midazolam was given at 0.8 mg.kg-1 x min-1 for 10 min and maintained at 0.04 mg.kg-1 x min-1 for 50 min (total 10 mg.kg-1). The diameter of arterioles and venules and rCBF showed no significant change. During the last 10 min of midazolam administration, flumazenil, given at 0.1 mg.kg-1 x min-1 for 10 min (total 1 mg.kg-1), caused an increase of MAP and rCBF (P < 0.01) at 5 min after infusion and diameter of larger arterioles (> 50 microns) and venules (50-100 microns) were dilated (P < 0.05). These results indicate that midazolam does not affect the diameter of cerebral arterioles and venules; however, the reversal effects of flumazenil against midazolam are transient vasodilation of larger arterioles accompanied by an elevation of MAP, and an increase in CBF.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8213021     DOI: 10.1111/j.1399-6576.1993.tb03766.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  2 in total

1.  Effects of topical and intravenous JM-1232(-) infusion on cerebrovascular reactivity in rats.

Authors:  Kenji Iwata; Hiroki Iida; Mami Iida; Naokazu Fukuoka; Kazuhiro Kito; Kumiko Tanabe
Journal:  J Anesth       Date:  2015-04-26       Impact factor: 2.078

2.  The effects of topical and intravenous JM-1232(-) on cerebral pial microvessels of rabbits.

Authors:  Kodai Ikemoto; Tadahiko Ishiyama; Noriyuki Shintani; Nobumasa Asano; Daniel I Sessler; Takashi Matsukawa
Journal:  BMC Anesthesiol       Date:  2015-03-20       Impact factor: 2.217

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.